Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis

Eliza Gordon-Lipkin, Peter Calabresi

Research output: Contribution to journalArticlepeer-review

Abstract

Optical coherence tomography (OCT) is a relatively new imaging technology that has been introduced as a powerful biomarker in neurological disease, including multiple sclerosis. In this review, OCT as an imaging technique, its reproducibility and validation in multiple sclerosis, application to other neurodegenerative diseases and future technological directions are discussed.

Original languageEnglish (US)
Pages (from-to)93-96
Number of pages4
JournalJournal of Neuroimmunology
Volume304
DOIs
StatePublished - Mar 15 2017

Keywords

  • Multiple sclerosis
  • Neurodegeneration
  • Neuroimaging
  • Optical coherence tomography

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis'. Together they form a unique fingerprint.

Cite this